HCPLive Network

AAN 2012: Interview with Dr. Zigmond about Exercise and Parkinson’s Disease Study [Podcast]

In this interview, Michael Zigmond, PhD, Professor of Neurology at theUniversity of Pittsburgh, discusses why he became involved with studying Parkinson’s disease and his research on exercise and Parkinson’s disease which he will be presenting at this year's AAN conference.

When asked about how he began his research in Parkinson's disease, Zigmond said, "I became interested in catecholamines, which includes dopamine and norepinephrine primarily, as a graduate student. There was evidence that they were affected by stress and I was interested in looking at the adaptive effects of stress."

It was upon collaborating with colleague when Zigmond explained how he "discovered that... physicial exercise was what we would call 'neuroprotective.' If you had animals exercise before you expose them to a toxin like 6-Hydroxydopamine, the effects of the toxin on the animals' behavior and on the dopamine neurons themselves was reduced."


 


Further Reading
Kidney donors may have lower 1,25-dihydroxyvitamin D and phosphate levels. Their parathyroid hormone levels may be elevated, but with minimal effect on calcium levels.
In the first test of an Ebola virus vaccine in the US, the University of Maryland announced it will soon start human trial.
Rare and potentially pathogenic variants in known amyotrophic lateral sclerosis genes are present in a considerable proportion of patients with familial and sporadic disease, and the burden of variants influences disease onset, according to a study published online Nov. 7 in the Annals of Neurology.
More Reading
Kidney donors may have lower 1,25-dihydroxyvitamin D and phosphate levels. Their parathyroid hormone levels may be elevated, but with minimal effect on calcium levels.